Hsu, F.-S.; Lin, W.-C.; Kuo, K.-L.; Chiu, Y.-L.; Hsu, C.-H.; Liao, S.-M.; Dong, J.-R.; Liu, S.-H.; Chang, S.-C.; Yang, S.-P.;
et al. PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. Int. J. Mol. Sci. 2021, 22, 11706.
https://doi.org/10.3390/ijms222111706
AMA Style
Hsu F-S, Lin W-C, Kuo K-L, Chiu Y-L, Hsu C-H, Liao S-M, Dong J-R, Liu S-H, Chang S-C, Yang S-P,
et al. PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. International Journal of Molecular Sciences. 2021; 22(21):11706.
https://doi.org/10.3390/ijms222111706
Chicago/Turabian Style
Hsu, Fu-Shun, Wei-Chou Lin, Kuan-Lin Kuo, Yen-Ling Chiu, Chen-Hsun Hsu, Shih-Ming Liao, Jun-Ren Dong, Shing-Hwa Liu, Shih-Chen Chang, Shao-Ping Yang,
and et al. 2021. "PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study" International Journal of Molecular Sciences 22, no. 21: 11706.
https://doi.org/10.3390/ijms222111706
APA Style
Hsu, F.-S., Lin, W.-C., Kuo, K.-L., Chiu, Y.-L., Hsu, C.-H., Liao, S.-M., Dong, J.-R., Liu, S.-H., Chang, S.-C., Yang, S.-P., Chen, Y.-T., Chang, R.-J., & Huang, K.-H.
(2021). PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. International Journal of Molecular Sciences, 22(21), 11706.
https://doi.org/10.3390/ijms222111706
